Keywords: |
adolescent; treatment outcome; aged; fludarabine; clinical feature; case report; antineoplastic agents; letter; skin defect; melphalan; punch biopsy; thiotepa; antibodies, monoclonal; myelodysplastic syndrome; panniculitis; ciprofloxacin; mycobacterium haemophilum; mycobacterium infections; systemic lupus erythematosus; clarithromycin; linezolid; immunocompromised host; doxycycline; bone marrow transplantation; fatal outcome; chronic lymphatic leukemia; rifampicin; antibiotic sensitivity; antibodies, neoplasm; immunosuppressive agents; alemtuzumab; mycobacteriosis; myelodysplastic syndromes; rifabutin; streptomycin; granulomatous inflammation; amikacin; gatifloxacin; skin diseases, bacterial; clofazimine; ethambutol; leg injury; saphenous vein; communicable diseases, emerging; leukemia, lymphoid
|